Drug maker GlaxoSmithKline plans to appeal a $2.5 million verdict in a lawsuit that alleged the company's antidepressant drug Paxil caused birth defects.
While a Philadelphia jury found GlaxoSmithKline guilty of negligence, it did not find the company guilty of outrageous conduct and rejected punitive damages. The verdict is the first of about 600 similar Paxil lawsuits filed across the United States, the Associated Press reported.
This lawsuit was launched by a Philadelphia family whose son was born four years ago with a number of heart defects.
In 2005, the U.S. Food and Drug Administration issued warnings that Paxil may be associated with birth defects, the AP reported.